Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Eye imaging to understand childhood myopia

Official title: Modélisation de l'œil Myope Infantile Par IRM et OCT

Run by Essilor International · NCT07335146 · Data updated 2026-11-12

This project uses detailed eye imaging (optical measurements and MRI) to see if differences in eye anatomy explain why some children with nearsightedness respond differently to treatments.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment100 (estimated)
SponsorEssilor International
Industry-sponsored
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07335146 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with a cycloplegic spherical equivalent between -6.5 D and +2.0 D who have social security coverage and parental consent are ideal candidates.

Probably not a fit

Children with neurological deficits, other progressive eye diseases, prior intraocular implants (aphakia/pseudophakia), ocular motility disorders (strabismus or nystagmus), or any contraindication to MRI are unlikely to be eligible or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study collects ophthalmic geometric and wavefront measurements alongside MRI scans to map eye anatomy in children with myopia or mild hyperopia. Participants will undergo noninvasive optical measurements and an MRI to capture internal eye structures and optical aberrations. By comparing anatomical features with known patterns of myopia progression and treatment response, researchers aim to identify anatomical markers that could guide personalized myopia control. The study is sponsored by Essilor International and conducted at Hôpital Fondation Adolphe de Rothschild in Paris.

Why it matters

Potential benefit: If successful, the findings could help clinicians tailor myopia treatments to a child’s eye anatomy, improving control of progression and reducing long-term vision risks.

How similar studies have gone: Prior research has linked axial length and corneal/optical metrics to myopia progression, but combining MRI with detailed wavefront and geometric measures to personalize treatment response remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spherical equivalent under cycloplegia greater -9.75 D and less than 2 D
* Beneficiary of social security
* Written consent from both holders of parental authority (or from one in case of exclusive parental authority)

Exclusion Criteria:

* Declared neurological deficit, including history of epileptic pathology or sensory-motor coordination disorders, vestibular or cerebellar pathology (for example, balance disorders)
* Current or progressive pathology of the eyes or their appendages that may affect vision, other than myopia (examples: glaucoma, retinitis pigmentosa…)
* Declared aphakia or pseudophakia (intraocular implant)
* Ocular motility problem such as strabismus or nystagmus
* Contraindication to MRI (claustrophobia, implanted devices such as pacemaker, etc.)
* Wearing fixed orthodontic appliances that affect the quality of orbital MRI scans

Where it's running

  • Hôpital Fondation Adolphe de Rothschild
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.